People

Feng Ding

Feng Ding joined the Xu Group in August of 2008 as a Ph.D. student in Biomedical Science in the Department of Chemistry and Biochemistry. He graduated from Soochow University, P.R.China in June of 2001 with his B.S. in Biotechnology.

His research project is focused on studying the mechanisms of ABC multidrug resistance transporters, which has received more and more attention during the past years. With the aim of understanding exactly how transporters work to efflux administered substrates (drug), we hope to combat this mechanism one day. This goal will bring hope to the global use of drug therapy and the big problem of multi-drug resistance bacteria due to their transporters.

Selected publications:

1. F. Ding, K. Lee, A. Vahedi-Faridi, T. Huang, X. Xu, "Design and Probing of Efflux Functions of EGFP fused ABC Membrane Transporters in Live Cells Using Fluorescence Spectroscopy", Anal. Bioanal. Chem., 400, 223-235 (2011).

2. K. Lee, L. Browning, T. Huang, F. Ding, P. Nallathamby, X. Xu*, "Probing multidrug ABC membrane transporters of single living cells using single nanoparticle plasmonic optical probes" Anal. Bioanal. Chem. 397, 3317-3328 (2010).

3. Xiangyang Xue a,1, Feng Ding a,1, Qingfeng Zhanga, Xuegong Panb, Li Qua, Weiqing Pana,*, Stability and potency of the Plasmodium falciparum MSP1-19/AMA-1(III) chimeric vaccine candidate with Montanide ISA720 adjuvant, Vaccine, 2009 (co-first authorship).

4. Qingfeng Zhang, Feng Ding, Xiangyang Xue, Xindong Xu and Weiqing Pan, Changing the N-terminal sequence protects recombinant Plasmodium falciparum circumsporozoite protein from degradation in Pichia pastoris, Appl Microbiol Biotechnol, 2007 Dec 20.